Microsphere Radioembolization for Liver Malignancies: A Technical Overview
نویسنده
چکیده
The incidence of the liver tumors is increasing worldwide; concurrently liver directed therapies are also evolving rapidly. Management of these complex disease processes involves a multidisciplinary approach, hence it is imperative to understand the underlying management principles thoroughly. This overview is intended to provide an easy, step by step approach to transcatheter brachytherapy, also known as radioembolization (RE). A brief overview of the anatomical issues, transcatheter technique and intraarterial RE will be provided.
منابع مشابه
Planning Arteriography for Yttrium-90 Microsphere Radioembolization.
Yttrium-90 radioembolization (Y RE) is a contemporary transcatheter locoregional therapy for primary and secondary hepatic malignancies that is commonly utilized in modern Interventional Radiology (IR) practice.1 Unlike other targeted endovascular therapies, such as transarterial chemoembolization (TACE) and transarterial embolization (TAE), the current standard of care protocol for Y RE treatm...
متن کاملYttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies that results in high tumor response rates and extended patient survival. To date, application of this therapy toward management of lung cancer he...
متن کاملRecommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
PURPOSE To standardize the indications, techniques, multimodality treatment approaches, and dosimetry to be used for yttrium-90 (Y90) microsphere hepatic brachytherapy. METHODS AND MATERIALS Members of the Radioembolization Brachytherapy Oncology Consortium met as an independent group of experts in interventional radiology, radiation oncology, nuclear medicine, medical oncology, and surgical ...
متن کاملYttrium-90 microsphere radioembolization for hepatocellular carcinoma.
Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile. Retrospective data show similar levels of effectiveness to transarterial chemoembolization in i...
متن کاملA hepatic dose-toxicity model opening the way toward individualized radioembolization planning.
UNLABELLED The 50% normal-tissue complication probability (NTCP) after lobar irradiation of the liver results in highly variable biologic effective doses depending on the modality used: a biologic effective dose for 50% (BED50) of 115, 93, and 250 Gy for external-beam radiotherapy, resin microsphere radioembolization, and glass microsphere radioembolization, respectively. This misunderstood pro...
متن کامل